Taysha Gene Therapies, Inc. TSHA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s total current liabilities?
- Taysha Gene Therapies, Inc. (TSHA) reported total current liabilities of $20.1M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s total current liabilities changed year-over-year?
- Taysha Gene Therapies, Inc.'s total current liabilities decreased by 10.9% year-over-year, from $22.56M to $20.1M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s total current liabilities has grown at a 30.1% compound annual growth rate (CAGR), from $7.13M to $26.55M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.